Philippines: fake drugs make up 25% of counterfeits

The National Committee on IP Rights of the Philippines prevented more than PHP455 million ($8.7 million) worth of counterfeit medicines and personal care products from reaching consumers in the first seven months of this year.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Europol notes ‘worrying trend’ in fake medicines

9 March 2020 EU authorities seized €7.9 million worth of counterfeit medicines—including fake cancer drugs, antivirals, and erectile dysfunction medicines—as part of an operation carried out last year.

Asia

Philippines IP office issues warning over fake drugs

15 October 2019 The Philippines’ deputy IP chief has warned e-commerce platforms that they could be made liable for the sale of counterfeit goods on their sites under new legislation, amid fears over the spread of counterfeit pharmaceuticals.

More features

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

Philippines: fake drugs make up 25% of counterfeits

More on this story

Editor's picks

Editor's picks

More features